A Orphenadrine Citrate, Norflex CEP of the European Pharmacopoeia monograph is often referred to as a Orphenadrine Citrate, Norflex Certificate of Suitability (COS). The purpose of a Orphenadrine Citrate, Norflex CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Orphenadrine Citrate, Norflex EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Orphenadrine Citrate, Norflex to their clients by showing that a Orphenadrine Citrate, Norflex CEP has been issued for it. The manufacturer submits a Orphenadrine Citrate, Norflex CEP (COS) as part of the market authorization procedure, and it takes on the role of a Orphenadrine Citrate, Norflex CEP holder for the record. Additionally, the data presented in the Orphenadrine Citrate, Norflex CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Orphenadrine Citrate, Norflex DMF.
A Orphenadrine Citrate, Norflex CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Orphenadrine Citrate, Norflex CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Orphenadrine Citrate, Norflex suppliers with CEP (COS) on PharmaCompass.